cough drug
Indian govt set to ban 1,200 fixed-dose combination drugs, reports
March 18, 2016Business Services, Medical Communications, Sales and Marketing Abbott Laboratories, Pfizer, cough drug, pharma
Indian regulators are set to ban an additional 1,200 fixed-dose combinations, sent for probe by Drug Controller General of India …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
